Post-Chemotherapy Management
The patient has right breast cancer and has undergone a total mastectomy and axillary lymph node dissection.
The pathology report indicates the following: Stage: IIB, Tumor size: 2.4 cm, Lymph nodes: positive for metastasis (2, 11), Distant metastasis: none, Tumor type: IDC ER: 90%, PR: 70%, HER-2: negative, Ki-67: 6%, Grade: 2.
She is currently undergoing chemotherapy (1-4 cycles of Adriamycin and Cyclophosphamide, 5-8 cycles of Paclitaxel) and is scheduled for the 8th cycle this week.
After the follow-up visit, the physician indicated that considering her physical condition and the pathology report, a consultation with a radiation oncologist will be conducted after chemotherapy to evaluate whether to proceed with radiation therapy and oral chemotherapy (the name of the oral medication is not remembered).
I would like to inquire about the key reasons for consulting the radiation oncologist to assess the need for additional radiation therapy and oral chemotherapy.
Additionally, since the patient has undergone axillary lymph node dissection, will radiation therapy cause lymphedema in the axilla? How can this be prevented and managed? Thank you, and I look forward to your clarification.
Pang Pang, 40~49 year old female. Ask Date: 2022/06/30
Dr. Chen Sirong reply Oncology
Patient: 46 years old, male
1.
I would like to ask, what are the key reasons for the consultation with the radiologist to assess whether additional radiation therapy and oral chemotherapy are necessary?
A: If the lymph nodes have not metastasized, and the tumor is less than 4 cm, after a total mastectomy, radiation therapy may not be required.
However, in some foreign hospitals, patients with only 1-3 metastatic lymph nodes who have already received chemotherapy may not undergo radiation therapy.
In Taiwan, it is generally recommended to proceed with radiation therapy.
2.
Additionally, since the patient's wife has undergone axillary lymph node dissection, will undergoing radiation therapy cause lymphedema in the axilla?
A: It is a matter of probability, but usually, the risk is low, meaning it does not commonly occur and may only happen under certain circumstances.
3.
How can it be avoided?
A: Avoid lifting heavy objects: use a cart for grocery shopping, do not carry children with the right arm.
These are instances where overuse of the right arm can occur, such as in my patient who is a seamstress and experienced swelling in her hand.
4.
What are the measures for relief?
A: If it occurs, relief may be slower.
The principle is to elevate the affected limb above the level of the heart to facilitate lymphatic return, for example, by propping up the right arm while sleeping at night.
5.
Generally, after normal treatment, significant lymphedema should not occur, as the swelling caused by the aforementioned situations (lifting heavy objects and overuse) is usually not severe and will gradually subside after elevating the arm.
However, if there is a recurrence of the disease, specifically the recurrence of axillary lymph nodes, it can obstruct lymphatic return, making the disease harder to control, and the issue of lymphatic blockage will worsen day by day, leading to significant swelling.
Wishing you a safe completion of your treatment.
Taoyuan Hospital
Dr.
Chen Sih-Rong
Reply Date: 2022/06/30
More Info
Post-chemotherapy management for breast cancer patients is a critical phase that requires careful consideration of various factors to ensure optimal recovery and minimize the risk of recurrence. In your wife's case, she has undergone a right breast mastectomy and axillary lymph node dissection, with a pathology report indicating stage IIB breast cancer. The tumor size is 2.4 cm, and there is lymph node involvement, which necessitates a comprehensive post-treatment plan.
Key Considerations in Post-Chemotherapy Management
1. Assessment for Radiation Therapy:
After completing chemotherapy, the oncologist will evaluate the need for radiation therapy (RT). This decision is based on several factors:
- Tumor Characteristics: The size, grade, and hormone receptor status of the tumor play a significant role. In your wife's case, the tumor is classified as invasive ductal carcinoma (IDC) with a high estrogen receptor (ER) positivity (90%) and a moderate progesterone receptor (PR) positivity (70%). HER2 negativity and a Ki-67 index of 6% suggest a lower proliferation rate, which may influence the decision for RT.
- Lymph Node Involvement: Since there is lymph node metastasis, radiation therapy is often recommended to target any residual cancer cells in the axillary region and reduce the risk of local recurrence.
- Patient's Overall Health: The patient's physical condition and any comorbidities will also be assessed to ensure they can tolerate additional treatments.
2. Oral Chemotherapy Medications:
The consideration of oral chemotherapy agents, such as capecitabine (often referred to as "截瘤達" in Chinese), is typically based on the risk of recurrence and the specific characteristics of the tumor. For patients with certain types of breast cancer, especially those with residual disease after chemotherapy, oral agents can provide additional systemic therapy to target any remaining cancer cells. The oncologist will weigh the potential benefits against the side effects and the patient's overall health status.
3. Management of Lymphedema:
Given that your wife has undergone axillary lymph node dissection, there is a risk of developing lymphedema, which is swelling due to lymph fluid accumulation. To mitigate this risk, the following strategies can be employed:
- Physical Therapy: Engaging in specialized lymphedema therapy can help manage and reduce swelling. This may include manual lymphatic drainage and exercises designed to promote lymphatic flow.
- Compression Garments: Wearing compression sleeves or garments can help prevent swelling and manage existing lymphedema.
- Education: Patients should be educated on self-care techniques, including skin care to prevent infections and recognizing early signs of lymphedema.
4. Follow-Up Care:
Regular follow-up appointments are essential for monitoring recovery and detecting any signs of recurrence early. This typically includes:
- Physical Examinations: Regular check-ups with the oncologist to assess any physical changes.
- Imaging Studies: Depending on the oncologist's recommendations, imaging studies may be performed periodically to monitor for any signs of recurrence.
- Hormonal Therapy: Given the hormone receptor-positive status of the tumor, adjuvant hormonal therapy (e.g., tamoxifen or aromatase inhibitors) may be recommended for five to ten years to reduce the risk of recurrence.
5. Lifestyle Modifications:
Encouraging a healthy lifestyle can significantly impact recovery and overall well-being. This includes:
- Nutrition: A balanced diet rich in fruits, vegetables, whole grains, and lean proteins can support recovery.
- Physical Activity: Engaging in regular physical activity, as tolerated, can improve physical and emotional health.
- Support Systems: Emotional support from family, friends, or support groups can help patients cope with the psychological aspects of cancer treatment.
In conclusion, post-chemotherapy management for breast cancer patients involves a multidisciplinary approach that includes evaluating the need for radiation therapy, considering additional systemic treatments, managing potential side effects like lymphedema, and ensuring regular follow-up care. It is crucial to maintain open communication with the healthcare team to address any concerns and to tailor the treatment plan to the patient's specific needs and circumstances.
Similar Q&A
Post-Surgery Treatment Considerations for HER2-Positive Breast Cancer Patients
1. The patient has stage I breast cancer (Estrogen receptor: negative / Progesterone receptor: negative / HER2: positive / Ki-67: 60%). The postoperative treatment recommendation is to undergo six cycles of chemotherapy combined with targeted therapy using the following three med...
Dr. Chen Jiaming reply Surgery
If there are concerns regarding the treatment in a clinical situation, it is advisable to discuss them with the attending physician, as online consultation information is insufficient to determine the appropriateness of treatment. The imaging reports prior to chemotherapy and the...[Read More] Post-Surgery Treatment Considerations for HER2-Positive Breast Cancer Patients
Post-Chemotherapy Management for Stage IIB Breast Cancer Patients
Right breast cancer, with complete mastectomy and axillary lymph node dissection performed. The pathology report is as follows: Stage: IIB, Tumor size: 2.4 cm, Lymph nodes: metastasis present (2, 11), Distant metastasis: none. Tumor type: IDC ER: 90%, PR: 70%, HER-2: negative, Ki...
Dr. Chen Ronghong reply Surgery
Hello, Pang Pang. Currently, in Taiwan, the indications for Atezolizumab are limited to pancreatic cancer, gastric cancer, colorectal cancer, and lung cancer. In Japan, it can be used for unresectable or recurrent breast cancer, but that is different from your situation. Therefor...[Read More] Post-Chemotherapy Management for Stage IIB Breast Cancer Patients
Post-Surgery Treatment Options for Stage I Breast Cancer: Key Considerations
Hello Doctor, my wife was diagnosed with breast cancer earlier this year at the age of 42. The pathology report after surgery is as follows: ER: 98+ PR: 98+ Her2: 2+ FISH: Negative Ki67: 9% Tumor size: 1.9 cm. During lymph node surgery, 4 nodes were removed and tested, with no me...
Dr. Hu Ziren reply Oncology
According to the report, the type of breast cancer is associated with a low risk of recurrence. It is recommended to follow the attending physician's advice to take Tamoxifen for 5-10 years and undergo postoperative radiotherapy, with regular follow-ups. There are no dietary...[Read More] Post-Surgery Treatment Options for Stage I Breast Cancer: Key Considerations
Understanding Post-Breast Cancer Treatment Options and Chemotherapy Insights
Hello, Dr. Lai! I would like to inquire about the follow-up treatment for breast cancer. The report states the following: Size: 22mm, Lymph nodes: no metastasis, Margins: clear, Distant metastasis: none, Stage: IIA, Classification: Luminal B type, ER: >90%, PR: 3%, HER2: 1+, K...
Dr. Lai Yicheng reply Oncology
Dear Miss Debbie, Thank you for your letter. Here is my response: HER2 is positive [+++], which indicates that targeted therapy can reduce the risk of recurrence or metastasis by one-third. If HER2 is positive [++], further FISH testing is required to confirm whether targeted ...[Read More] Understanding Post-Breast Cancer Treatment Options and Chemotherapy Insights
Related FAQ
(Oncology)
Side Effects Of Chemotherapy(Oncology)
Leukemia(Oncology)
Breast Adenoma(Oncology)
Medication Consultation(Oncology)
Terminal Stage(Oncology)
Palliative Care(Oncology)
Other(Oncology)
Anemia(Oncology)
Thrombocytosis(Oncology)